Gestational Diabetes

The results of this study suggest that the use of certain types of hormonal contraceptives during the 5 years leading up to a pregnancy may be associated with the risk of developing gestational diabetes.

Minor elevations in glucose during pregnancy are associated with a significantly increased risk of having an infant with an abnormal testicular descent, also known as congenital cryptorchidism, the results of a case-control study suggest.

Only 45% women in the cohort underwent postpartum glucose testing, as recommended.

Women with gestational diabetes can be accurately identified by measuring fasting capillary glucose.

Among women with a family history of type 2 diabetes, those with prior GDM were more likely to have CVD risk factors.

The offspring of women with pregestational diabetes, either type 1 or type 2, are at a three-fold increased risk for perinatal mortality, and a two-fold increased risk for congenital anomalies, compared with the general population.

In women in whom prenatal care is the first medical care they receive, screening for gestational diabetes before they are 24 weeks pregnant could help identify those with pre-gestational diabetes mellitus.

Fasting blood glucose and HbA1c testing can be a useful screening tool for gestational diabetes. c Control in Diabetes Showed a Significant Improvement When Compared to Standard Therapy.

Women who are physically active before pregnancy are less likely to develop gestational diabetes mellitus (GDM), and the GDM risk also rises with the amount of pre-pregnancy television viewing, a new study shows.

Although the use of metformin in gestational diabetes is not yet accepted as treatment in gestational diabetes, evidence is accumulating that it may be a useful treatment.